Novan Announces Statistically Significant Phase 2 Clinical Trial Results for SB206
November 29, 2016 06:05 ET
|
Novan, Inc.
Number of Patients with Complete Clearance of Genital Warts Provides Clinical Evidence of Nitric Oxide Anti-Viral Activity Against HPV Company Plans End-of-Phase 2 Meeting for First Half of...